Skip to main content
. 2018 Sep 11;289(3):775–785. doi: 10.1148/radiol.2018180092

Table 1:

Demographics and Clinical and Cognitive Information

graphic file with name radiol.2018180092.tbl1.jpg

Note.—Unless otherwise specified, data are means ± standard deviations. AD = Alzheimer disease, ADAS-Cog = Alzheimer’s Disease Assessment Scale-Cognitive subscale, ChEI = cholinesterase inhibitor, CSF = cerebrospinal fluid, HC = healthy control participants, MCI = mild cognitive impairment.

*Data are numbers, with percentages in parentheses.

Significant level at P ˂ .05.

In total, eight patients with early MCI and 13 patients with late MCI had ADAS-Cog score 6 months after undergoing ChEI treatment. Among these patients, six patients with early MCI and 12 patients with late MCI patients had good-quality resting-state functional MR images at 6 months after undergoing ChEI treatment.